118 related articles for article (PubMed ID: 23343308)
21. Application of face centred central composite design to optimise compression force and tablet diameter for the formulation of mechanically strong and fast disintegrating orodispersible tablets.
Pabari RM; Ramtoola Z
Int J Pharm; 2012 Jul; 430(1-2):18-25. PubMed ID: 22465631
[TBL] [Abstract][Full Text] [Related]
22. Formulation development and optimization of Ibuprofen tablets by direct compression method.
Bushra R; Shoaib MH; Aslam N; Hashmat D; Ur-Rehman M
Pak J Pharm Sci; 2008 Apr; 21(2):113-20. PubMed ID: 18390440
[TBL] [Abstract][Full Text] [Related]
23. Predicting the dissolution behavior of pharmaceutical tablets with NIR chemical imaging.
Yekpe K; Abatzoglou N; Bataille B; Gosselin R; Sharkawi T; Simard JS; Cournoyer A
Int J Pharm; 2015; 486(1-2):242-51. PubMed ID: 25835268
[TBL] [Abstract][Full Text] [Related]
24. Formulation and evaluation of Cetirizine dihydrochloride orodispersible tablet.
Subramanian S; Sankar V; Manakadan AA; Ismail S; Andhuvan G
Pak J Pharm Sci; 2010 Apr; 23(2):232-5. PubMed ID: 20363705
[TBL] [Abstract][Full Text] [Related]
25. Investigation into liquisolid system processability based on the SeDeM Expert System approach.
Vasiljević I; Turković E; Nenadović S; Mirković M; Zimmer A; Parojčić J; Aleksić I
Int J Pharm; 2021 Aug; 605():120847. PubMed ID: 34216763
[TBL] [Abstract][Full Text] [Related]
26. Application of the SeDeM Expert System in Studies for Direct Compression Suitability on Mixture of Rhodiola Extract and an Excipient.
Wan S; Yang R; Zhang H; Li X; Gu M; Guan T; Ren J; Sun H; Dai C
AAPS PharmSciTech; 2019 Feb; 20(3):105. PubMed ID: 30746569
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the 3D microstructure of Ibuprofen tablets by means of synchrotron tomography.
Neumann M; Cabiscol R; Osenberg M; Markötter H; Manke I; Finke JH; Schmidt V
J Microsc; 2019 May; 274(2):102-113. PubMed ID: 30829393
[TBL] [Abstract][Full Text] [Related]
28. Fast dispersible ibuprofen tablets.
Schiermeier S; Schmidt PC
Eur J Pharm Sci; 2002 Apr; 15(3):295-305. PubMed ID: 11923062
[TBL] [Abstract][Full Text] [Related]
29. Effects of material properties and speed of compression on microbial survival and tensile strength in diclofenac tablet formulations.
Ayorinde JO; Itiola OA; Odeniyi MA
Arch Pharm Res; 2013 Mar; 36(3):273-81. PubMed ID: 23471558
[TBL] [Abstract][Full Text] [Related]
30. Cohesive, multicomponent, dense powder flow characterization by NIR.
Benedetti C; Abatzoglou N; Simard JS; McDermott L; Léonard G; Cartilier L
Int J Pharm; 2007 May; 336(2):292-301. PubMed ID: 17240094
[TBL] [Abstract][Full Text] [Related]
31. Formulation Study of a Co-Processed, Rice Starch-Based, All-in-One Excipient for Direct Compression Using the SeDeM-ODT Expert System.
Trisopon K; Kittipongpatana N; Wattanaarsakit P; Kittipongpatana OS
Pharmaceuticals (Basel); 2021 Oct; 14(10):. PubMed ID: 34681271
[TBL] [Abstract][Full Text] [Related]
32. Design and study of ibuprofen disintegrating sustained-release tablets comprising coated pellets.
Abbaspour MR; Sadeghi F; Afrasiabi Garekani H
Eur J Pharm Biopharm; 2008 Mar; 68(3):747-59. PubMed ID: 17977701
[TBL] [Abstract][Full Text] [Related]
33. Processability evaluation of multiparticulate units prepared by selective laser sintering using the SeDeM Expert System approach.
Vasiljević I; Turković E; Piller M; Mirković M; Zimmer A; Aleksić I; Ibrić S; Parojčić J
Int J Pharm; 2022 Dec; 629():122337. PubMed ID: 36309293
[TBL] [Abstract][Full Text] [Related]
34. Co-proccessed excipients with enhanced direct compression functionality for improved tableting performance.
Rojas J; Buckner I; Kumar V
Drug Dev Ind Pharm; 2012 Oct; 38(10):1159-70. PubMed ID: 22966909
[TBL] [Abstract][Full Text] [Related]
35. [Release of diltiazem chloride and ibuprofen from hydrophilic matrix tablets].
Vostalová L; Rabisková M; Medvecká G
Ceska Slov Farm; 2003 Nov; 52(6):295-8. PubMed ID: 14661369
[TBL] [Abstract][Full Text] [Related]
36. Pharmacotechnical and analytical preformulation studies for cannabidiol orodispersible tablets.
Vlad RA; Antonoaea P; Todoran N; Muntean DL; Rédai EM; Silași OA; Tătaru A; Bîrsan M; Imre S; Ciurba A
Saudi Pharm J; 2021 Sep; 29(9):1029-1042. PubMed ID: 34588849
[TBL] [Abstract][Full Text] [Related]
37. Development and evaluation of controlled release ibuprofen matrix tablets by direct compression technique.
Patel N; Madan P; Lin S
Pharm Dev Technol; 2011 Feb; 16(1):1-11. PubMed ID: 20491616
[TBL] [Abstract][Full Text] [Related]
38. Application of guar gum biopolymer in the prescription of tablets with sodium ibuprofen--quality tests and pharmaceutical availability in vitro.
Berner-Strzelczyk A; Kołodziejska J; Zgoda MM
Polim Med; 2006; 36(4):3-11. PubMed ID: 17402228
[TBL] [Abstract][Full Text] [Related]
39. Immediate release of ibuprofen from Fujicalin®-based fast-dissolving self-emulsifying tablets.
Kang MJ; Jung SY; Song WH; Park JS; Choi SU; Oh KT; Choi HK; Choi YW; Lee J; Lee BJ; Chi SC
Drug Dev Ind Pharm; 2011 Nov; 37(11):1298-305. PubMed ID: 21476949
[TBL] [Abstract][Full Text] [Related]
40. Fast dispersible/slow releasing ibuprofen tablets.
Fini A; Bergamante V; Ceschel GC; Ronchi C; de Moraes CA
Eur J Pharm Biopharm; 2008 May; 69(1):335-41. PubMed ID: 18182280
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
